Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Tekla Life Sciences Investors HQL NYSE

NYSE • Financial Services • Asset Management • US • USD

SharesGrow Score
89/100
4/6 Pass
SharesGrow Intrinsic Value
$86.78
+388.9%

Analyst Consensus — HQL

No analyst consensus data available for HQL.

People Also View

UTF
UTF
Cohen & Steers Infrastructure Fund, Inc
$26.48
-0.86%
 RVT
RVT
Royce Value Trust Inc.
$18.13
+1.17%
 EVT
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$25.73
+0.94%
 ETG
ETG
Eaton Vance Tax-Advantaged Global Dividend Income Fund
$21.85
+1.49%
 FPF
FPF
First Trust Intermediate Duration Preferred & Income Fund
$18.38
+1.16%
 HQH
HQH
Tekla Healthcare Investors
$19.76
+1.96%
 RNP
RNP
Cohen & Steers REIT and Preferred Income Fund, Inc.
$20.66
-0.65%
 FFC
FFC
Flaherty & Crumrine Preferred Securities Income Fund Inc.
$16.02
+0.25%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message